World's Best Scientists 2026 revealed!
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
98
Citations
44593
World Ranking
8805
National Ranking
125

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Juan J. Gomez-Reino is affiliated with the University of Santiago de Compostela in Spain and specializes in Medicine with a focus on Rheumatology.

Their research covers multiple subfields including Rheumatology, Immunology, Hematology, Genetics, and Pathology and Forensic Medicine. The main topics studied are:

  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Spondyloarthritis Studies and Treatments
  • Systemic Lupus Erythematosus Research
  • Biosimilars and Bioanalytical Methods
  • Chronic Lymphocytic Leukemia Research
  • Psoriasis: Treatment and Pathogenesis

Their publication record includes numerous papers in various scientific venues, with frequent contributions to the following journals:

  • Annals of the Rheumatic Diseases
  • ACR Open Rheumatology
  • Seminars in Arthritis and Rheumatism
  • RMD Open
  • Patient Preference and Adherence

Among recent research outputs are the following publications:

  • Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial, 2022, Annals of the Rheumatic Diseases
  • Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies, 2020, Annals of the Rheumatic Diseases
  • After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries, 2022, Annals of the Rheumatic Diseases
  • Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis, 2021, RMD Open
  • Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain, 2021, Patient Preference and Adherence

Frequent coauthors in their research collaborations include:

  • Carlos Sánchez-Piedra
  • Manuel Pombo-Suárez
  • Federico Díaz-González
  • Jon T. Giles
  • Alexis Ogdie

Best Publications

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

    Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk

  • Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report

    Juan J. Gómez-Reino;Loreto Carmona;Vicente Rodríguez Valverde;Emilio Martín Mola

  • Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.

    Mark C. Genovese;James D. McKay;Evgeny L. Nasonov;Eduardo F. Mysler

  • Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

    Wolfgang Hueber;Dhavalkumar D. Patel;Thaddeus Dryja;Andrew M. Wright

  • Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: The AMBITION study

    Graeme Jones;Anthony Sebba;Jieruo Gu;Mitchell B Lowenstein

  • Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.

    Arthur Kavanaugh;Iain McInnes;Philip Mease;Gerald G. Krueger

  • Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

    Loreto Carmona;Juan J. Gómez-Reino;Vicente Rodríguez-Valverde;Dolores Montero

  • Adipokines as emerging mediators of immune response and inflammation

    Francisca Lago;Carlos Dieguez;Juan Gómez-Reino;Oreste Gualillo

  • Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    D. Aletaha;R.B. Landewe;T. Karonitsch;J. Bathon

  • Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis

    Miguel Otero;Rocio Lago;Rodolfo Gomez;Francisca Lago

  • The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

    I. Solovic;M. Sester;J. J. Gomez-Reino;H. L. Rieder

  • Leptin, from fat to inflammation: old questions and new insights

    Miguel Otero;Rocı́o Lago;Francisca Lago;Felipe F. Casanueva

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

  • Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

    Arthur F Kavanaugh;Philip J Mease;Juan Jesus Gomez-Reino;Adewale O Adebajo

  • Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.

    Juan J Gómez-Reino;Loreto Carmona;Miguel Angel Descalzo

  • The emerging role of adipokines as mediators of inflammation and immune responses

    Francisca Lago;Carlos Dieguez;Juan Gómez-Reino;Oreste Gualillo

  • Leptin in the interplay of inflammation, metabolism and immune system disorders

    Vanessa Abella;Morena Scotece;Javier Conde;Jesús Pino

Frequent Co-Authors

Antonio Gonzalez
Antonio Gonzalez University of Santiago de Compostela
Oreste Gualillo
Oreste Gualillo Servicio Gallego de Salud
Loreto Carmona
Loreto Carmona Instituto de Salud Musculoesquelética
Francisco J. Blanco
Francisco J. Blanco University of A Coruña
John Loughlin
John Loughlin Newcastle University
Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Alejandro Balsa
Alejandro Balsa Hospital Universitario La Paz
Tore K. Kvien
Tore K. Kvien University of Oslo
Paul Emery
Paul Emery University of Leeds
Andrew Carr
Andrew Carr University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing careers in healthcare, there are several flexible online degree options to consider. Online nursing programs, in particular, have become increasingly popular for their accessibility and accelerated pathways.

If you are already a registered nurse seeking to advance your qualifications, online rn to bsn programs without clinical requirements offer an efficient route to earning your BSN without added clinical hours, making them ideal for busy professionals. Those looking to further their education and leadership in nursing can explore advanced options like dnp online programs and investigate the easiest dnp programs for a streamlined path to a Doctor of Nursing Practice degree.

Aspiring nurses just starting their journey may want to consider fast-paced entry-level options, such as an lpn fast track program that can quickly lead to licensure and employment. Exploring these varied online degrees can open many rewarding career pathways in healthcare.

Best Scientists Citing Juan J. Gomez-Reino

Trending Scientists